Isis Pharma (ISIS) Tops Q3 EPS by 1c
Get Alerts ISIS Hot Sheet
Join SI Premium – FREE
Isis Pharma (NASDAQ: ISIS) reported Q3 EPS of ($0.30), $0.01 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $49.1 million versus the consensus estimate of $52.93 million.
For earnings history and earnings-related data on Isis Pharma (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Logistic Properties of the Americas (LPA) Reports Q2 results
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share